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Abstract 
 
Aims/hypothesis To examine the associations between objectively measured sedentary time, 
breaks in sedentary time, moderate-to-vigorous physical activity (MVPA) and total physical 
activity with markers of cardio-metabolic health in a population at a high risk of type 2 
diabetes mellitus.  
 
Methods This study reports data from two ongoing diabetes prevention programmes. 
Participants at a high risk of type 2 diabetes were recruited from primary care practices 
located within the East Midlands, United Kingdom, 2010-2011, using either a validated risk 
score or medical records.  Sedentary time (<100counts/min), MVPA (≥1952counts/min) and 
total physical activity (counts) were measured using Actigraph GT3X accelerometers (15s 
epochs). A break was considered as any interruption in sedentary time (≥100counts/min). 
Linear regression analysis examined the associations with markers of cardio-metabolic health.  
 
Results 878 participants comprising 153 from ‘Project STAND’ (age=32.9±5.6years; 
female=71.2%) and 725 from ‘Walking Away from Diabetes’ (age=63.7±7.8years; 
female=35.2%). Following adjustment for various covariates, including MVPA, there were 
detrimental linear associations of sedentary time with 2-hour plasma glucose (standardised 
beta co-efficient (β)) (β=0.220, p=<0.001), triglycerides (β=0.206, p=0.001) and HDL 
cholesterol (β=-0.123, p=0.029). In contrast, after adjustment for sedentary time, MVPA was 
significantly inversely associated with BMI (β=-0.215, p=<0.001) and waist circumference 
(β=-0.228, p=<0.001), but not with measured biochemical variables. Breaks in sedentary time 
were inversely associated with waist circumference (β=-0.215, p=<0.001) and BMI (β=-
0.151, p=0.001).  Total physical activity was  
 
Conclusions/Interpretation In adults at high risk of type 2 diabetes mellitus, time spent 
sedentary is strongly and adversely associated with cardio-metabolic health. Furthermore, 
sedentary time may be a more important indicator of poor health than MVPA. 
 
 
Walking Away from Type 2 Diabetes Study - ISRCTN31392913. 
Project STAND (Sedentary Time And Diabetes) - ISRCTN08434554. 
 
Keywords: Breaks in sedentary time, High-risk, Physical activity, Primary care, Sedentary 
behaviour, Type 2 diabetes mellitus.  
 
Abbreviations:  
β- Beta-coefficient 
cpm- Counts per minute 
CVD- Cardiovascular disease 
FPG- Fasting plasma glucose 
IFG- Impaired fasting glycaemia 
IGR- Impaired glucose regulation 
IGT- Impaired glucose tolerance 
IMD- Index of multiple deprivation 
MVPA- Moderate-to-vigorous physical activity 
METs- Metabolic equivalents 
STAND- Sedentary Time And Diabetes 
UK- United Kingdom 
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WA- Walking Away from type 2 diabetes 
Introduction 
 
Sedentary behaviour has previously been characterised as ≤1.5 metabolic equivalents (METs) 
[1, 2].  METs are the energy cost of physical activity and are expressed as multiples of resting 
metabolic rate- where one MET (or 3.5 ml min-1 kg-1) is equivalent to a typical metabolism at 
rest for an average person. Given the fact it is impractical to measure energy expenditure in 
most studies and there are limited behaviours that involve both sitting and energy expenditure 
(>1.5 METs), a more operational behavioural interpretation has been recommended, where 
sedentary behaviour is defined as any non-exercise sitting time [3]. Over the last decade, 
sedentary behaviour has emerged as a distinctive behavioural paradigm with detrimental 
effects on chronic disease risk, independent of moderate- to vigorous-intensity physical 
activity (MVPA) [4-8]. This new paradigm is conceptualised around two constructs: total 
time spent sedentary and the number of breaks in sedentary behaviour (e.g. rising from a 
sitting/lying position to standing). Both expressions show strong associations with markers of 
cardio-metabolic health independent of each other and other lifestyle behaviours [4-6, 8, 9].  
 
Epidemiological evidence examining the effect of time spent sedentary has tended to focus on 
self-report measures [6, 10-12], which are prone to bias and have poor levels of validity [13]. 
Although several studies employing objective measures of sedentary behaviour have been 
reported, most have been conducted in the general population [4, 5, 8, 14, 15]. It is therefore 
unclear to what extent the reported associations are generalisable to those at high risk of 
chronic disease. This is an important limitation as international recommendations and policies 
specify that chronic disease prevention strategies should include targeted interventions aimed 
at the identification and management of high risk individuals [16-18]. Therefore the 
importance of sedentary behaviour in this group needs to be better understood in order to 
inform the content and structure of prevention programmes. 
 
The effect of age on the association between sedentary time and cardio-metabolic risk also 
remains unclear. Many studies involving children and adolescents have reported minimal or 
no associations between sedentary time and markers of cardio-metabolic health and evidence 
in young adults remains limited, particularly in high risk populations [19, 20].  
 
In this study, we examined the extent to which sedentary time, breaks in sedentary time, and 
MVPA are independently associated with cardio-metabolic risk factors in a population 
identified with a high risk of developing type 2 diabetes mellitus.  We hypothesised that all 
three constructs would be independently associated with health.  
 
Methods 
 
Participants This study used combined baseline data two prevention studies, Walking Away 
from Type 2 Diabetes Study (WA) (ISRCTN31392913) and Project STAND (Sedentary Time 
And Diabetes) (ISRCTN08434554), 2010-2011. Both trial protocols have been published 
elsewhere [21, 22]. Briefly, WA is a randomised controlled trial investigating whether a 
lifestyle intervention programme can promote behaviour change in those identified at high 
risk of type 2 diabetes mellitus. Similarly, Project STAND is a randomised controlled trial 
investigating the effect of structured education and self monitoring on reducing sedentary 
time in young adults identified at high risk of developing type 2 diabetes mellitus.  
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Individuals were unaware of their diabetes risk status before entering both studies and all 
participants were excluded if they had known type 2 diabetes mellitus or were taking steroids. 
Baseline measurements across both studies were performed before treatment allocation by the 
same team of trained staff who followed identical standard operating procedures. Informed 
consent obtained from all eligible participants and both studies gained full ethical and 
governance approvals from the Nottingham Research Ethics Committee and Leicestershire, 
Northamptonshire and Rutland Comprehensive Local Research Network. 
 
Walking Away Middle age and older adults (aged up to 74) were recruited from 10 primary 
care practices within Leicestershire, United Kingdom (UK). Individuals at high risk of 
impaired glucose regulation (IGR) (composite of impaired glucose tolerance (IGT) and/or 
impaired fasting glycaemia (IFG)) or type 2 diabetes mellitus were identified using a 
modified version of the automated Leicester Risk Score, specifically designed to be 
administered in primary care [23]. An automated platform using medical records was used to 
rank individuals for diabetes risk using predefined weighted variables (age, gender, BMI, 
family history of type 2 diabetes mellitus and use of antihypertensive medication).  Those 
scoring within the 90th percentile in each practice were invited to take part in the study. This 
approach has been shown to have reasonable sensitivity and specificity for identifying 
participants at a high risk of IGR [23].  
 
Project STAND Young adults who were at risk of developing type 2 diabetes mellitus from 
across Leicestershire and the South East Midlands region were recruited from primary care 
practices. Practices databases were searched for participants meeting the following inclusion 
criteria: a) aged 18-40 years with a BMI in the obese range (≥30kg/m2; ≥27.5kg/m2 for south 
Asians) or b) aged 18-40 years with a BMI in the overweight range ≥25kg/m2 (≥23kg/m2 for 
south Asians) plus one additional risk factor of a family history of type 2 diabetes mellitus or 
cardiovascular disease (CVD), previous gestational diabetes, polycystic ovarian syndrome, 
HbA1c ≥5.8% or IGR [24].  
 
Cardiovascular, metabolic and anthropometric outcomes Markers of metabolic and 
cardiovascular health were measured, including fasting plasma glucose (FPG) and 2-hour 
plasma glucose (via an OGTT), HbA1c, total cholesterol, HDL cholesterol and triglycerides. 
Venous blood samples were obtained following an overnight fast and all assays were 
measured in the same laboratory located within the Leicester Royal Infirmary, UK. Analysis 
was conducted by individuals blinded to the patients' identity, using stable methodologies, 
standardised to external quality assurance values. Plasma glucose was analysed in venous 
samples via the hexokinase method. HbA1c was analysed using the Bio-Rad Variant II HPLC 
system (Bio-Rad Clinical Diagnostics, Hemel Hempstead, UK). HDL-cholesterol and 
triglycerides were measured using standard enzymatic techniques.  
 
Body weight (Tanita TBE 611, Tanita, West Drayton, UK) and waist circumference 
(midpoint between the lower costal margin and iliac crest) were measured to the nearest 0.1 
kg and 0.5 cm respectively. Information on current smoking status, medication and ethnicity 
was obtained following an interview administered protocol with a health care professional. 
Social deprivation was determined by assigning an Index of Multiple Deprivation (IMD) 
score to the participant’s resident area [25]. IMD scores are publically available continuous 
measures of compound social and material deprivation which are calculated using a variety of 
data including current income, employment, education and housing. 
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Accelerometer measures Participants were asked to wear a tri-axial accelerometer (Actigraph 
GT3X, Florida, USA) on the right midaxillary line of the hip (attached via a waistband), for a 
minimum of seven consecutive days during waking hours. These accelerometers translate raw 
accelerations into activity counts and Freedson cut-offs were used to categorise MVPA 
(≥1952 counts per minute (cpm)) and sedentary behaviour (<100cpm) [26]. A break was 
considered as an interruption in sedentary time in which the accelerometer count rose up to or 
above 100cpm [4, 8]. Accelerometers were initialised to record activity in 5s epochs in the 
STAND cohort and 15s epochs in the WA cohort. In order to allow for direct comparison, all 
data was analysed using 15s epochs, following epoch preprocessor conversion in the STAND 
cohort. 
 
Non-wear time was defined as a minimum of 60 minutes of continuous zero counts and days 
with at least 600 minutes wear time were considered valid [4, 5, 14]. In order for data to be 
included in the analysis, participants required at least four valid days [27].  
 
A physical activity data analysis tool (ActiSCi, Suffolk, UK) was used to derive wear time, 
apply cut-points for sedentary time and MVPA and undertake epoch preprocesser conversions 
(5s to 15s). 
 
Statistical analysis Statistical analyses were performed using PASW Statistics v18.0. Due to 
their skewed distribution, FPG, 2-hour glucose, HDL-cholesterol, triglycerides and HDL: 
total cholesterol ratio were log-transformed.  
 
Forced-entry linear regression analysis was used on the combined study cohorts to examine 
independent associations of sedentary time, breaks in sedentary time and MVPA with markers 
of metabolic (FPG, 2-hour glucose, waist circumference, BMI, HbA1c) and cardiovascular 
health (triglycerides, HDL cholesterol and HDL: total cholesterol ratio).  
 
Model 1 was adjusted for age, gender, smoking status, ethnicity, social deprivation, lipid 
lowering  and beta-blocker medication, family history of type 2 diabetes mellitus, days 
accelerometer worn and time accelerometer worn (average minutes per day).  Model 2 was 
additionally adjusted for MVPA time (minutes per day) and the associations for breaks and 
MVPA were examined having also adjusted for sedentary time (minutes per day). In order to 
examine the extent to which adiposity may attenuate these relationships, model 3 was further 
adjusted for BMI.  
 
Significant associations were followed up with interaction terms to assess differences in the 
strength of the associations between sedentary time, breaks in sedentary time and MVPA by 
study group and sex, using a model adjusted for the above covariates. To further represent the 
strength of sedentary time and breaks in sedentary time with cardio-metabolic markers, 
variables were also examined as tertiles using analysis of covariance (ANCOVA) procedures. 
 
In order to enable direct comparison to previous published studies, a sensitivity analysis was 
conducted to investigate whether results were affected by integrating the measure of sedentary 
time to 60s epochs.  
 
Two-tailed p values of 0.05 or less were considered statistically significant for main effects. 
Adjustment was not made for multiple comparisons, therefore data were viewed with caution 
and in relation to the overall pattern of results. p<0.1 was considered significant for 
interactions. Due to log-transformation, and to allow for direct comparisons across cardio-
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metabolic markers, results of the linear regression analysis are presented as the standardised 
beta co-efficient (β)±SE. 
 
Results 
 
In total, 153 younger participants from Project STAND (age=32.9±5.6years; female=71.2%) 
and 725 older participants from WA (age=63.7±7.8years; female=35.2%) had valid measures 
of both objective activity and biochemical variables. This equated to 87% of the combined 
cohort.  The majority of excluded participants failed to meet the minimum accelerometer wear 
time requirement. Those included in this analysis had a similar ethnic breakdown and social 
deprivation score compared to those who did not reach the minimum accelerometer criteria. 
However, those excluded were more likely to be younger (51.3±14.6 vs. 58.4±13.8years, 
p<0.001) with a larger waist circumference (105.4±15.4 vs. 101.6±12.0cm, p<0.001) and 
BMI (34.6±6.7 vs. 32.5±5.2kg/m2, p<0.001). Table 1 reports the demographic, cardio-
metabolic, anthropometric and accelerometer characteristics of included participants. 
 
Accelerometer wear time (14.5±1.4 vs. 14.4±1.4hours per day) and sedentary time (10.3±1.5 
vs. 10.3±1.5hours) were similar between study cohorts. The younger STAND cohort spent a 
longer time engaged in MVPA (interquartile range; 0.7 (0.4-0.9) vs. 0.5 (0.3-0.9hours)). 
Sedentary time and breaks showed small correlations in the STAND (r=-0.208, p<0.01) and 
WA (r=-0.106, p=0.01) cohorts. MVPA had an inverse correlation with sedentary time 
(STAND; rs=-0.328, p<0.001; WA; rs=-0.363, p<0.001) and a small association with breaks 
(STAND; rs=0.246, p<0.01; WA; rs=0.215, p<0.001). 
 
Sedentary Time Table 2 displays the overall associations in the combined cohort of total 
sedentary time with biomedical and anthropometric markers. After adjustments for known 
confounders, including MVPA and BMI, sedentary time showed a detrimental association 
with 2-hour glucose (β=0.220±0.060, p=<0.001), HDL-cholesterol (β=-0.123±0.056, 
p=0.029) and triglycerides (β=0.206±0.061, p=0.001).  
 
MVPA MVPA was significantly inversely associated with 2-hour glucose (β=-0.121±0.035, 
p=<0.001), triglycerides (β=-0.149±0.036, p=<0.001), total cholesterol:HDL ratio (β=-
0.124±0.034, p=<0.001), HDL cholesterol (β=0.150±0.033, p=<0.001), BMI (β=-
0.241±0.031, p=<0.001) and waist circumference (β=-0.270±0.033, p=<0.001). However, 
after adjustment for sedentary time, only BMI (β=-0.215±0.041, p=<0.001) and waist 
circumference (β=-0.228±0.043, p=<0.001) remained significant.   
 
Breaks in sedentary time Table 2 also reports the associations of breaks in sedentary time with 
the same markers of health. Independent of known confounders (including sedentary time), 
breaks in sedentary behaviour were significantly inversely associated with 2-hour glucose 
(β=-0.111±0.055, p=0.046) waist circumference (β=-0.215±0.051, p=<0.001) and BMI (β=-
0.151±0.049, p=0.003). However, further adjustment for BMI attenuated the association with 
2-hour glucose.  
 
Results reported above were unaffected if waist circumference rather than BMI was used in 
Model 3. 
 
Figure 1 illustrates the associations between sedentary time and 2-hour glucose, HDL-
cholesterol and triglycerides when examined as tertiles. Figure 2 shows the association of 
breaks with waist circumference and BMI.   
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Interaction analyses indicated a significant effect for study cohort, with the older cohort 
demonstrating greater associations of MVPA with BMI (p for interaction <0.001) and waist 
circumference (p for interaction <0.001). For breaks in sedentary time, the same pattern was 
observed, with the older cohort achieving a stronger association for waist circumference (p for 
interaction=<0.001) and BMI (p for interaction=<0.001). No other significant interactions 
were observed for the effect of study group. In addition, there were no significant interactions 
for sex in the results for sedentary time, MVPA or breaks. 
 
The pattern of results and significance levels were unaffected if data were analysed at 60s 
epochs. However, standardised beta-coefficients were consistently around 10% lower 
reflecting the less sensitive nature of the data at longer epochs (data available on request).  
 
Discussion 
 
This study of those at a high risk of type 2 diabetes mellitus recruited from primary care 
found that sedentary time was detrimentally associated with 2-hour glucose, triglycerides and 
HDL-cholesterol, independent of measured confounders. These results remained significant 
after further adjustment for measures of adiposity. Furthermore, the findings for biochemical 
factors were consistent across groups with diverse age ranges, providing evidence that the 
deleterious consequences of excess sedentary time exist across young to old adults. 
Interestingly, sedentary time was shown to have stronger associations with several important 
cardio-metabolic markers (2-hour glucose, triglycerides, HDL-cholesterol) than MVPA, after 
adjustment for each other and other important known confounders. Associations of breaks in 
sedentary time with markers of health, independent of overall time spent sedentary and in 
MVPA, were less consistent, although beneficial associations were observed with measures of 
adiposity.  To our knowledge, this is the first study to examine the effect of sedentary time 
and breaks on markers of cardio-metabolic health in a primary care population at high risk of 
type 2 diabetes mellitus.  
 
Our study has multiple strengths; most notably it provides novel evidence in a high risk 
population recruited through primary care using an objective measure of sedentary time, 
across a wide age range. Furthermore, all participants were from the same geographical 
location, with similar risk profiles and measurements across both studies were performed by 
the same team of trained staff, following identical standard operating procedures. In addition, 
participants were rigorously phenotyped with traditional markers of cardio-metabolic health 
using standardised biochemical procedures.  Limitations include the cross-sectional design 
which limits inference about the direction of causality between the sedentary variables and 
markers of cardio-metabolic health; reverse causality remains a possibility. Despite allowing 
for more robust assessments of sedentary behaviour compared to self-report, accelerometers 
are not without limitations. For example, they rely on categorising movement (acceleration) 
strength, rather than directly distinguishing between sitting, lying and standing behaviours. 
 
Our results extend those from other studies that have utilised both self-reported and objective 
measures of sedentary time and MVPA with cardio-metabolic variables in the general 
population. Self-reported sedentary behaviour in the form of television viewing time has been 
positively associated with a multitude of cardio-metabolic risk factors [6, 28-30], including 2-
hour glucose [28, 29]. Similarly, recent reviews also report that self-reported sedentary time is 
consistently associated with an increased risk of diabetes [9] and the metabolic syndrome 
[31].  
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Several studies have examined the joint effect of sedentary behaviour and physical activity on 
health outcomes [5, 32, 33]. In contrast to our observations, most have concluded that 
physical activity is a stronger predictor of metabolic risk [32] and insulin resistance [33]. This 
discrepancy in findings may be due to differences in study populations, as our participants 
had been identified as being at high risk of type 2 diabetes mellitus, were largely obese and 
spent longer in sedentary pursuits. Our population is representative of those that are likely to 
be identified as being at high risk of type 2 diabetes mellitus within routine care and referred 
onto available prevention programmes.  
 
Our study was not able to corroborate previous findings that breaks in sedentary behaviour are 
independently associated with glucose regulation and triglycerides [8].  However, in contrast 
to overall sedentary behaviour, strong associations were observed between breaks and 
measures of adiposity (waist circumference and BMI), even after adjustment for MVPA and 
total time spent sedentary.  Therefore, this study suggests that breaks in sedentary behaviour, 
rather than total sedentary time per se may be an important factor in the regulation of body 
weight.  
  
The non-significant results observed for FPG and HbA1c are consistent with previous 
research on physical activity and sedentary behaviour [4, 14, 34] and reflect the different 
pathophysiological process underlying 2-hour and FPG regulation, with 2-hour glucose 
largely influenced by peripheral insulin resistance [34, 35]. Our findings, therefore, highlight 
the importance of using 2-hour glucose as the primary outcome variable when assessing the 
impact of sedentary time on cardio-metabolic risk.   
 
Animal models have confirmed that distinctive physiological pathways are activated with 
increased sedentary behaviour, particularly around the metabolism of lipoprotein lipase, 
which remains largely unaffected by MVPA [36]. Lipoprotein lipase is a key regulator of 
lipid metabolism and is causally linked to CVD [37]. In addition, sedentary behaviour may 
also reduce glucose transporter protein content, thus exacerbating insulin resistance [38].   
 
Whilst the mounting epidemiological evidence linking sedentary behaviour with cardio-
metabolic variables is supported by plausible mechanistic pathways that have been tested in 
animal models, published experimental research in humans is largely lacking. To date, only 
one intervention study focused specifically on sedentary behaviour in adults has been 
published. Nineteen overweight/obese adults showed large reductions in the area under the 
glucose and insulin curve when sitting time was regularly punctuated with short periods of 
both light and moderate intensity activity [39].  Surprisingly, there was no difference between 
the effect sizes found in the light or moderate intensity profiles. Although encouraging, the 
findings from this study need to be confirmed in different populations in order to establish a 
causal link between sedentary behaviour and cardio-metabolic dysfunction.  
 
In conclusion, the findings from this study may have important methodological and public 
health implications. This study provides novel objective evidence that in individuals at high 
risk of type 2 diabetes mellitus, sedentary time may be a more important indicator of cardio-
metabolic health than MVPA. Therefore, diabetes and cardiovascular prevention programmes 
concentrating solely on MVPA may overlook an area that is of fundamental importance to 
cardio-metabolic health. Along with messages around accumulating at least 150 minutes per 
week of MVPA, which form the corner-stone of diabetes prevention programmes [40], such 
interventions may be more effective if individuals are further encouraged to reduce their 
sedentary time and to break up periods of prolonged sitting. Nevertheless, given the 
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limitations, this study should not be used to confirm a direct link between sitting time and 
metabolic health, but should act as a stimulus for tightly controlled intervention studies in 
different populations in order to influence future physical activity and sedentary behaviour 
interventions and public health initiatives aimed at disease prevention. 
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Tables 
Table 1 Demographics, metabolic, anthropometric and accelerometer characteristics of 
participants 
 
aMeans adjusted for lipid lowering medication  
bMeans adjusted for the time the accelerometer was worn  
Sedentary time = <100 cpm, light intensity activity 100-1,951 cpm, and MVPA ≥1952 cpm 
Continuous parametric results as mean±SD, number (column percentage) and continuous 
non-parametric results as median (interquartile range) 
 
Characteristics STAND  
(N=153) 
Walking Away 
(N=725) 
All  
(N=878) 
Age (years) 32.9 ± 5.6 63.7 ± 7.8 58.4 ± 13.8 
Male 44 (28.8) 470 (64.8) 514 (58.5) 
Current Smokers 57 (37.3) 62 (8.5) 119 (13.6) 
Family History of Diabetes (1st degree) 100 (65.4) 261 (35.9) 361 (41.1) 
Cardio-metabolic variables 
BMI (kg/m2) 34.6 ± 4.8 31.2 ± 5.3 32.5 ± 5.2 
Waist circumference (cm) 102.9 ± 13.5 101.3 ± 11.7 101.6 ± 12.0 
Weight (kg) 98.3 ± 17.3 91.5 ± 16.5 92.7 ± 16.9 
FPG (mmol/L) 4.8 (4.5-5.1) 5.2 (4.9-5.6) 5.1 (4.8-5.5) 
2-hour plasma glucose (mmol/L) 5.3 (4.5-6.4) 6.1 (4.9-7.8) 5.9 (4.8-7.5) 
Body Fat (%) 40.5 ± 7.2 35.6 ± 8.7 36.5 ± 8.6 
Total Cholesterol (mmol/L)a 4.8 (4.2-5.4) 5.1 (4.3-5.9) 5.0 (4.3-5.8) 
HDL Cholesterol (mmol/L)a 1.2 (1.0-1.4) 1.4 (1.1-1.6) 1.3 (1.1-1.6) 
Total Cholesterol: HDL Ratio (mmol/L)a 3.9 (3.2-4.7) 3.7 (3.0-4.4) 3.8 (3.0-4.5) 
Triglycerides (mmol/L)a 1.30 (0.90-1.70) 1.30 (1.00-1.80) 1.30 (1.00-1.80) 
Lipid Lowering Medication 1 (0.6) 240 (33.1) 241 (27.4) 
Beta-blockers 2 (1.3) 127 (15.2) 129 (14.7) 
HbA1c (%) 5.6 (5.3-5.8) 5.9 (5.6-6.1) 5.8 (5.6-6.1) 
Ethnicity 
White European 
South Asian 
Other 
 
128 (83.7) 
15 (9.8) 
10 (6.5) 
 
645 (89.0) 
53 (7.3) 
27 (3.7) 
 
773 (88.0) 
68 (7.8) 
37 (4.2) 
Diagnosis 
Normal glucose tolerance 
Isolated IFG 
Isolated IGT 
Both 
Type 2 diabetes mellitus 
All (IGR) 
 
137 (89.5) 
3 (1.9) 
11 (7.2) 
1 (0.7) 
1 (0.7) 
16 (10.4) 
 
512 (70.6) 
38 (5.2) 
124 (17.1) 
31 (4.3) 
20 (2.8) 
214 (29.5) 
 
649 (73.9) 
41 (4.7) 
135 (15.4) 
32 (3.6) 
21 (2.4) 
230 (26.2) 
Accelerometer variables (time in hours) 
Time accelerometer worn 14.5 ± 1.4 14.4 ± 1.4 14.4 ± 1.4 
Sedentary Timeb 10.3 ± 1.5 10.3 ± 1.5 10.3 ± 1.5 
Light-intensity activityb 3.5 ± 0.9 3.5 ± 0.9 3.5 ± 0.9 
MVPAb 0.7 (0.4-0.9) 0.5 (0.3-0.9) 0.6 (0.3-0.9) 
Accelerometer variables (percent at each activity level) 
Sedentary time 70.5 ± 7.6 71.5 ± 7.8 71.0 ± 8.0 
Light-intensity activity 24.3 ± 6.5 24.3 ± 6.3 24.3 ± 6.4 
MVPA 4.7 (2.8-6.2) 3.7 (2.1-5.9) 3.9 (2.3-6.0) 
Breaks per day 297 ± 68 273 ± 60 277 ± 62 
Average steps per day 7153 ± 2954 6993 ± 3384 7016 ± 3313  
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Table 2 Multiple linear regression models for sedentary time, moderate-to-vigorous physical 
activity and breaks in sedentary time with cardio-metabolic variables 
Model 1 
 Sedentary 
Time 
(<100cpm) 
β (SE) 
p value MVPA 
(≥1952cpm) 
 
β (SE) 
p value Breaks  
 
β (SE) 
p value 
2-hour glucose (mmol/L) 0.238 (0.045) <0.001 -0.121 (0.035) 0.001 -0.180 (0.038) <0.001 
Waist circumference (cm) 0.250 (0.043) <0.001 -0.270 (0.033) <0.001 -0.198 (0.037) <0.001 
BMI (Kg/m2) 0.210 (0.041) <0.001 -0.241 (0.031) <0.001 -0.148 (0.035) <0.001 
Triglycerides (mmol/L) 0.217 (0.045) <0.001 -0.149 (0.036) <0.001 -0.150 (0.040) <0.001 
Fasting Glucose (mmol/L) 0.046 (0.045) 0.308 -0.033 (0.036) 0.488 -0.024 (0.038) 0.777 
Total Cholesterol:HDL Ratio 0.130 (0.043) 0.003 -0.124 (0.034) <0.001 -0.114 (0.037) 0.003 
HDL Cholesterol (mmol/L) -0.187 (0.042) <0.001 0.150 (0.033) <0.001 0.130 (0.036) <0.001 
HbA1c (%) 0.035 (0.050) 0.489 -0.034 (0.046) 0.464 -0.021 (0.038) 0.590 
Model 2 
 Sedentary 
Time 
(<100cpm) 
β (SE) a 
p value MVPA 
(≥1952cpm) 
 
β (SE) b 
p value Breaks  
 
β (SE) c 
p value 
2-hour glucose (mmol/L) 0.235 (0.060) <0.001 -0.033 (0.047) 0.473 -0.111 (0.055) 0.046 
Waist circumference (cm) 0.091 (0.057) 0.113 -0.228 (0.043) <0.001 -0.215 (0.051) <0.001 
BMI (Kg/m2) 0.054 (0.053) 0.327 -0.215 (0.041) <0.001 -0.151 (0.049) 0.003 
Triglycerides (mmol/L) 0.214 (0.062) 0.001 -0.042 (0.048) 0.385 -0.046 (0.056) 0.418 
Fasting Glucose (mmol/L) 0.023 (0.062) 0.714 -0.021 (0.048) 0.662 -0.011 (0.038) 0.903 
Total Cholesterol:HDL Ratio 0.101 (0.058) 0.085 -0.075 (0.045) 0.096 -0.075 (0.054) 0.167 
HDL Cholesterol (mmol/L) -0.137 (0.056) 0.016 0.083 (0.044) 0.060 0.071 (0.052) 0.175 
HbA1c (%) 0.014 (0.051) 0.836 -0.013 (0.036) 0.725 -0.035 (0.056) 0.537 
Model 3 
 Sedentary 
Time 
(<100cpm) 
β (SE) a 
p value MVPA 
(≥1952cpm) 
 
β (SE) b 
p value Breaks  
 
β (SE) c 
p value 
2-hour glucose (mmol/L) 0.220 (0.060) <0.001 -0.019 (0.055) 0.678 -0.095 (0.056) 0.091 
Triglycerides (mmol/L) 0.206 (0.061) 0.001 -0.011 (0.050) 0.826 -0.019 (0.056) 0.736 
Fasting Glucose (mmol/L) 0.011 (0.063) 0.857 -0.009 (0.047) 0.850 0.000 (0.050) 0.993 
Total Cholesterol:HDL Ratio 0.090 (0.057) 0.120 -0.037 (0.045) 0.412 -0.044 (0.053) 0.408 
HDL Cholesterol (mmol/L) -0.123 (0.056) 0.029 0.041 (0.043) 0.344 0.035 (0.051) 0.495 
HbA1c (%) 0.008 (0.062) 0.898 -0.010 (0.046) 0.828 -0.022 (0.054) 0.689 
 
Model 1 was adjusted for age, gender, smoking status, ethnicity, social deprivation, family 
history, beta blockers, lipid lowering medication and time accelerometer worn 
Model 2 was adjusted for the above covariates and aMVPA, bsedentary time or csedentary 
time and MVPA 
Model 3 was adjusted for the same covariates as Model 2 and BMI 
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Figure 1 Tertiles of sedentary time with 2-hour glucose (a), log-triglycerides (b) and 
HDL-cholesterol (c).  Estimated marginal means are adjusted for age, gender, 
ethnicity, IMD score, smoking status, family history of type 2 diabetes mellitus, lipid 
lowering medication, beta blockers, time accelerometer worn, days accelerometer 
worn, time spent in MVPA and BMI. Tertile cut-points for sedentary time were 9.6 
and 10.9hours/day. Medians and ranges for tertile 1 = 8.7hours (2.9-9.5); tertile 2= 
10.3hours (9.6-10.9); tertile 3= 11.7hours (11.0-15.8). p<0.001 for trend (a), p<0.05 
for trend (b, c). 
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Figure 2 Tertiles of breaks in sedentary time with waist circumference (a) and BMI 
(b).  Estimated marginal means are adjusted for age, gender, ethnicity, IMD score, 
smoking status, family history of type 2 diabetes mellitus, lipid lowering medication, 
beta blockers, time accelerometer worn, days accelerometer worn and time spent in 
sedentary and MVPA. Cut points for daily breaks in sedentary time were 234 and 285. 
Medians and ranges for tertile 1 = 215 (33-234); tertile 2= 268 (235-284); tertile 3= 
329 (285-487). p<0.001 for trend (a), p<0.01 for trend (b) 
 
